Nuveen Asset Management, LLC Biotechnology

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
KOD Kodiak Sciences Inc.	$289M	$379,000 0.0% of portfolio	145,449	Q4 2023 Added 2.66%
VTYX Ventyx Biosciences, Inc.	$97.8M	$367,000 0.0% of portfolio	168,420	Q3 2024 Added 25.65%
XOMA Xoma Corp	$296M	$366,000 0.0% of portfolio	13,836	Q2 2024 Added 38.53%
ADGI Adagio Therapeutics, Inc.	$505M	$354,000 0.0% of portfolio	107,119	Q2 2024 New
TCRX T Scan Therapeutics, Inc.	$41.3M	$348,000 0.0% of portfolio	69,962	Q2 2024 New
XFOR X4 Pharmaceuticals, Inc	$36.4M	$334,000 0.0% of portfolio	498,745	Q2 2024 Added 13.84%
TRVI Trevi Therapeutics, Inc.	$247M	$321,000 0.0% of portfolio	96,350	Q2 2024 Added 28.73%
ENOB Enochian Biosciences Inc	$244M	$304,000 0.0% of portfolio	66,288	Q2 2024 New
MRSN Mersana Therapeutics, Inc.	$72.9M	$285,000 0.0% of portfolio	151,201	Q3 2024 Added 22.59%
ATOS Atossa Therapeutics, Inc.	$97.5M	$259,000 0.0% of portfolio	170,733	Q2 2024 New
PEPG Pep Gen Inc.	$31.7M	$244,000 0.0% of portfolio	28,557	Q2 2024 Added 106.22%
CVAC Cure Vac N.V.	$671M	$244,000 0.0% of portfolio	83,219	Q4 2023 New
CDXC Chroma Dex Corp.	$377M	$241,000 0.0% of portfolio	66,114	Q2 2024 New
BLUE Bluebird Bio, Inc.	$485M	$213,000 0.0% of portfolio	409,857	Q1 2024 Added 32.52%
ELYM Eliem Therapeutics, Inc.	$109M	$198,000 0.0% of portfolio	39,034	Q3 2024 New
ABOS Acumen Pharmaceuticals, Inc.	$58.7M	$194,000 0.0% of portfolio	78,446	Q3 2024 Added 38.44%
ALXO Alx Oncology Holdings Inc	$44.4M	$192,000 0.0% of portfolio	105,894	Q4 2023 Added 20.81%
XBIT X Biotech Inc.	$96.5M	$192,000 0.0% of portfolio	24,879	Q2 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$28.2M	$186,000 0.0% of portfolio	99,346	Q3 2024 Reduced 41.62%
STTK Shattuck Labs, Inc.	$51.3M	$185,000 0.0% of portfolio	53,038	Q2 2024 New
IPSC Century Therapeutics, Inc.	$43M	$180,000 0.0% of portfolio	105,650	Q2 2024 Added 75.97%
RAPT Rapt Therapeutics, Inc.	$34.4M	$156,000 0.0% of portfolio	77,709	Q2 2024 Reduced 26.7%
HOWL Werewolf Therapeutics, Inc.	$40.2M	$155,000 0.0% of portfolio	73,370	Q3 2024 Added 40.97%
PBYI Puma Biotechnology, Inc.	$127M	$142,000 0.0% of portfolio	55,922	Q2 2024 New
OVID Ovid Therapeutics Inc.	$47.2M	$140,000 0.0% of portfolio	119,113	Q1 2024 Added 4.41%
VERU Veru Inc.	$44.9M	$137,000 0.0% of portfolio	178,557	Q2 2024 New
RGLS Regulus Therapeutics Inc.	$17.4M	$134,000 0.0% of portfolio	85,602	Q2 2024 New
FENC Fennec Pharmaceuticals Inc.	$173M	$130,000 0.0% of portfolio	26,006	Q1 2024 Added 6.32%
ELEV Elevation Oncology, Inc.	$14.7M	$104,000 0.0% of portfolio	174,137	Q3 2024 Added 114.49%
CHRS Coherus Bio Sciences, Inc.	$87.1M	$98,000 0.0% of portfolio	95,056	Q1 2024 Reduced 87.51%
INMB Inmune Bio, Inc.	$172M	$89,000 0.0% of portfolio	16,518	Q2 2024 New
AVTE Aerovate Therapeutics, Inc.	$62.1M	$83,000 0.0% of portfolio	40,047	Q4 2023 Added 10.29%
GALT Galectin Therapeutics Inc	$77.8M	$75,000 0.0% of portfolio	27,623	Q2 2024 New
PRLD Prelude Therapeutics Inc	$36.7M	$34,000 0.0% of portfolio	16,797	Q4 2023 Added 21.68%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	157,951	Q3 2024 Added 2.28%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.